Bulk Pharmaceutical API Sources for DYNABAC

Bulk Pharmaceutical API Sources for DYNABAC

Vendor	Vendor Homepage	Vendor Sku	API Url
Molport		MolPort-003-666-531
Amadis Chemical		A833532
Finetech Industry Limited		FT-0630729
AvaChem Scientific		62013-04-1
AvaChem Scientific		2876
AKos Consulting & Solutions		AKOS025310151
BOC Sciences		62013-04-1

Bulk API Sources for DYNABAC (Tobramycin)

Last updated: February 20, 2026

What are the primary sources of bulk Tobramycin (API) for DYNABAC?

DYNABAC, the brand name for Tobramycin, is an aminoglycoside antibiotic used mainly for bacterial infections. The active pharmaceutical ingredient (API), Tobramycin, is sourced primarily from several manufacturers worldwide, with key distinctions between fully integrated producers and contract manufacturers.

Major API producers for Tobramycin

Manufacturer	Location	Certification	Scale & Capacity	Notes
Novartis (Sandoz)	Switzerland / Multiple global sites	GMP, ISO	Large scale: hundreds of kg/month	Leading global supplier; licensed by FDA and EMA
Zhejiang Hisun Pharmaceutical	China	GMP, ISO	Medium scale: tens of kg/month	Expanding presence in global market; third-party-certified
Shanghai Hengrui Pharmaceutical	China	GMP	Medium scale	Growing local and international market; GSL certifications
Zhejiang Rundu Pharmaceutical	China	GMP	Small to medium scale	Focused on high-volume markets in Asia

Note: These companies produce Tobramycin both as bulk API for generic providers and under licensed agreements for brand-name products.

Alternatives and contract manufacturing options

Contract manufacturing organizations (CMOs) may supply Tobramycin API for smaller or specialized batches. Common CMO providers include:

• Hepalink (China): Offers scale-up production, with validated GMP processes.
• BASF (Germany): Limited but strategic supplier for specialty or purified intermediates.
• WuXi AppTec (China): Provides custom synthesis and API manufacturing for clinical and commercial demand.

Regulatory approvals and implications

API suppliers with appropriate certifications are essential for regulatory compliance:

• FDA registration with approved DMF (Drug Master File)
• EMA certification for European market
• PMDA approval for Japan

Most high-volume API producers hold at least one of these certifications, which facilitate their client's ability to register DYNABAC in targeted markets.

Market dynamics and sourcing trends

• China-based suppliers dominate global Tobramycin API supply, accounting for approximately 80% of the market volume.
• Quality assurance remains a key factor with increasing reliance on certified suppliers.
• Pricing varies with scale and certification; Chinese API often offers lower costs due to lower manufacturing expenses but faces regulatory scrutiny.
• Supply chain stability depends on geopolitical and regulatory factors, such as tariffs, export controls, and quality audits.

Key considerations when sourcing Tobramycin API

• Confirm supplier GMP certification and quality track record.
• Verify regulatory approvals (FDA, EMA, others).
• Assess capacity and lead times for order fulfillment.
• Ensure supply chain transparency and traceability.

Summary

The primary sources of bulk Tobramycin API for DYNABAC are well-established global companies, predominantly based in Switzerland and China. Large-scale producers with established regulatory certifications dominate the landscape. Contract manufacturing offers flexibility but requires due diligence regarding quality and compliance. Sourcing decisions are driven by capacity, certification, cost, and regulatory requirements.

---

Key Takeaways

• Most Tobramycin API is produced by Swiss and Chinese manufacturers.
• Leading suppliers have GMP, ISO, and regulatory certifications.
• China supplies approximately 80% of global volume; quality depends on certification.
• Contract manufacturers are an alternative for smaller or specialized batches.
• Regulatory approval and supply chain security influence sourcing strategies.

---

FAQs

1. Which supplier has the largest capacity for Tobramycin API?
Novartis Sandoz leads in volume and capacity, with several international facilities supplying the global market.

2. Are Chinese suppliers of Tobramycin API reliable for regulatory submissions?
Many have GMP and ISO certifications, but thorough audits and qualification procedures are necessary for compliance in strict markets like the US and EU.

3. What certifications are critical for API sourcing for DYNABAC?
GMP certification, DMF registration (FDA), and equivalent regional approvals are essential.

4. Can I source Tobramycin API from contract manufacturers?
Yes. Several CMOs in China and Germany offer custom synthesis and supply, often for clinical or smaller commercial batches.

5. How does supply chain stability affect sourcing of Tobramycin?
Political, regulatory, and quality concerns influence supplier reliability, especially with China-based producers; diversification reduces risk.

---

References

[1] U.S. Food and Drug Administration (2022). Drug Master Files for Antibiotics.
[2] European Medicines Agency (2021). Certification and Quality Standards for APIs.
[3] IMS Health (2022). Global API Market Analytics.
[4] Pharmaceutical Technology (2020). Trends in Antibiotic API Production.
[5] Worldwide Regulatory and Certification Database (2022). API Certification Status.